71 related articles for article (PubMed ID: 11001817)
1. Definition of a "functional R domain" of the cystic fibrosis transmembrane conductance regulator.
Chen JM; Scotet V; Ferec C
Mol Genet Metab; 2000; 71(1-2):245-9. PubMed ID: 11001817
[TBL] [Abstract][Full Text] [Related]
2. Biochemical implications of sequence comparisons of the cystic fibrosis transmembrane conductance regulator.
Tan AL; Ong SA; Venkatesh B
Arch Biochem Biophys; 2002 May; 401(2):215-22. PubMed ID: 12054472
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane conductance regulator: the purified NBF1+R protein interacts with the purified NBF2 domain to form a stable NBF1+R/NBF2 complex while inducing a conformational change transmitted to the C-terminal region.
Lu NT; Pedersen PL
Arch Biochem Biophys; 2000 Mar; 375(1):7-20. PubMed ID: 10683244
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase A regulates ATP hydrolysis and dimerization by a CFTR (cystic fibrosis transmembrane conductance regulator) domain.
Howell LD; Borchardt R; Kole J; Kaz AM; Randak C; Cohn JA
Biochem J; 2004 Feb; 378(Pt 1):151-9. PubMed ID: 14602047
[TBL] [Abstract][Full Text] [Related]
5. N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel.
Gené GG; Llobet A; Larriba S; de Semir D; Martínez I; Escalada A; Solsona C; Casals T; Aran JM
Hum Mutat; 2008 May; 29(5):738-49. PubMed ID: 18306312
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the protein phosphatase 2A with the regulatory domain of the cystic fibrosis transmembrane conductance regulator channel.
Vastiau A; Cao L; Jaspers M; Owsianik G; Janssens V; Cuppens H; Goris J; Nilius B; Cassiman JJ
FEBS Lett; 2005 Jun; 579(16):3392-6. PubMed ID: 15936019
[TBL] [Abstract][Full Text] [Related]
7. Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens.
Radpour R; Gourabi H; Gilani MA; Dizaj AV; Rezaee M; Mollamohamadi S
Mol Hum Reprod; 2006 Nov; 12(11):717-21. PubMed ID: 16973827
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
9. A combined analysis of the cystic fibrosis transmembrane conductance regulator: implications for structure and disease models.
Chen JM; Cutler C; Jacques C; Boeuf G; Denamur E; Lecointre G; Mercier B; Cramb G; Férec C
Mol Biol Evol; 2001 Sep; 18(9):1771-88. PubMed ID: 11504857
[TBL] [Abstract][Full Text] [Related]
10. Association of the cystic fibrosis transmembrane regulator with CAL: structural features and molecular dynamics.
Piserchio A; Fellows A; Madden DR; Mierke DF
Biochemistry; 2005 Dec; 44(49):16158-66. PubMed ID: 16331976
[TBL] [Abstract][Full Text] [Related]
11. Misfolding of the cystic fibrosis transmembrane conductance regulator and disease.
Cheung JC; Deber CM
Biochemistry; 2008 Feb; 47(6):1465-73. PubMed ID: 18193900
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA.
Chappe V; Hinkson DA; Zhu T; Chang XB; Riordan JR; Hanrahan JW
J Physiol; 2003 Apr; 548(Pt 1):39-52. PubMed ID: 12588899
[TBL] [Abstract][Full Text] [Related]
13. Domain interdependence in the biosynthetic assembly of CFTR.
Cui L; Aleksandrov L; Chang XB; Hou YX; He L; Hegedus T; Gentzsch M; Aleksandrov A; Balch WE; Riordan JR
J Mol Biol; 2007 Jan; 365(4):981-94. PubMed ID: 17113596
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel.
Linsdell P
Exp Physiol; 2006 Jan; 91(1):123-9. PubMed ID: 16157656
[TBL] [Abstract][Full Text] [Related]
15. On the structural organization of the intracellular domains of CFTR.
Moran O
Int J Biochem Cell Biol; 2014 Jul; 52():7-14. PubMed ID: 24513531
[TBL] [Abstract][Full Text] [Related]
16. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.
Du K; Sharma M; Lukacs GL
Nat Struct Mol Biol; 2005 Jan; 12(1):17-25. PubMed ID: 15619635
[TBL] [Abstract][Full Text] [Related]
17. [Functional characterization of naturally occurring CFTR mutants: interest for cystic fibrosis].
Romey MC
Ann Biol Clin (Paris); 2006; 64(5):429-37. PubMed ID: 17040873
[TBL] [Abstract][Full Text] [Related]
18. Interhelical hydrogen bonds in the CFTR membrane domain.
Therien AG; Grant FE; Deber CM
Nat Struct Biol; 2001 Jul; 8(7):597-601. PubMed ID: 11427889
[TBL] [Abstract][Full Text] [Related]
19. Intermolecular interaction between R domains of cystic fibrosis transmembrane conductance regulator.
Gupta S; Xie J; Ma J; Davis PB
Am J Respir Cell Mol Biol; 2004 Feb; 30(2):242-8. PubMed ID: 12933354
[TBL] [Abstract][Full Text] [Related]
20. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
Li C; Naren AP
Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
